|
Sep 27
|
Compugen to Present New Clinical and Pre-Clinical Data in Multiple Presentations at SITC 2023
|
|
Jul 17
|
Compugen Wins on PVRIG European Patent Opposition Pursued by GSK and a Third Party
|
|
Apr 27
|
Compugen to Present New Clinical Data Showing Preliminary Anti-Tumor Activity of COM701 Triple Combination in Recurrent MSS-Metastatic Endometrial Cancer at ASCO 2023
|
|
Apr 26
|
Compugen to Present Data on its Lead Pre-Clinical Asset COM503 in an Oral Presentation at the 20th CIMT Annual Meeting
|